Real-World Outcomes of Stapokibart-Based Combination Therapy for Bullous Pemphigoid: A Single-Center Retrospective Cohort

2026-06-29

PRE

Si-Hang Wang

Si-Han Liu

Jie Zhang

Hanlin Zhang

Yan Wang

Si-Zhe Li

Ya-Gang Zuo *

DOI：10.1093/ced/llag269

Original request for help

Save

Abstract

En 中文

Bullous pemphigoid (BP) affects older adults and treatment is often limited by corticosteroid toxicity. Evidence for stapokibart in BP is limited.